Why is Balaxi Pharma falling/rising?

As of 04-Jul, Balaxi Pharmaceuticals Ltd is currently priced at Rs 49.35, reflecting an increase of Rs 0.48 or 0.98%. The stock is trading close to its 52-week low, just 1.66% away from Rs 48.53. Despite this slight uptick, the stock has underperformed in the past week, down 1.40%, and has seen a significant decline of 31.75% year-to-date. The company's long-term fundamentals appear strong, with a high average Return on Equity (ROE) of 30.97% and substantial growth in net sales and operating profit. However, the stock has generated a staggering return of -58.71% over the past year, indicating ongoing challenges, including a recent decline in profit after tax.
In the broader market context, Balaxi Pharmaceuticals has underperformed compared to the Sensex, which has gained 7.68% year-to-date. The stock's recent performance today has outpaced its sector by 0.85%, suggesting some positive investor sentiment. However, the stock is trading below all key moving averages, indicating a bearish trend. Additionally, while there has been a rise in investor participation, with delivery volume increasing by 57.3%, the overall negative returns over the past year and flat quarterly results raise concerns about its long-term viability. Thus, despite some positive indicators, the stock's overall trajectory remains downward in the context of broader market performance.